Noman masana'antu na hemp yana fuskantar babban haɓakawa a cikin Amurka saboda sabbin dokokin tarayya da buƙatar masu amfani. Waɗannan canje-canjen majalisu, wani ɓangare na Dokar Inganta Aikin Noma na 2018, bisa doka ta ba da izinin masu bincike su gudanar da gwaje-gwaje akan hemp da ba da damar masu shuka su shuka tsire-tsire.
A cikin 2021 hemp, tare da tarin THC na kasa da 0,3 bisa dari ta busassun nauyi, wanda aka girma a kan kadada 54.000 wanda ya fi dala miliyan 824, a cewar Ma'aikatar Aikin Noma ta Amurka. Tare da haɗin gwiwar Jami'ar York a Ontario, Kanada, da Cibiyar Nazarin Ci gaba da Bincike a Danville, Virginia, masu bincike daga Kwalejin Noma da Kimiyyar Rayuwa sun sami kyautar $ 600.000 don nazarin cannabinoid biosynthesis.
Ƙananan asarar CBD da fa'ida daga sauran cannabinoids
Ingantacciyar fahimtar waɗannan hanyoyin na iya ba da damar mafi kyawun zaɓi ko daidaitawar tsirrai tare da abun ciki na cannabinoid da aka bayar, mai yuwuwar haɓaka riba da rage haɗari ga masu shuka. Wannan saboda amfanin gona mai fiye da izinin abun ciki na THC dole ne a lalata shi.
Binciken kuma zai iya taimakawa masana'antar harhada magunguna kamar yadda cannabinoids ya zama mafi mahimmanci don maganin ciwo, damuwa, farfadiya da ciwon daji. "Muna da jerin abubuwan da aka rubuta guda tara da muke so mu kara bincike don ganin idan sun daidaita maganganun wadannan kwayoyin halittar da ke cikin cannabinoid biosynthesis," in ji Bargmann, mataimakin farfesa a Makarantar Shuka da Kimiyyar Muhalli.
"Idan za mu iya nemo hanyoyin da za a iya sarrafa biosynthesis, za mu iya shuka tsire-tsire ba kawai a cikin THC da CBD ba, har ma da yawan adadin cannabinoids kamar CBG (cannabigerol) da CBN (Cannabinol) da sauransu. Ta haka za mu iya noman amfanin gona da ke da darajar tattalin arziki fiye da yadda muke da ita a yanzu.”
Source: www.news-medical.net (En)
